Skip to main content

Nonprofit · EIN 16-1513923

WORLD FEDERATION OF HEMOPHILIA USA

Tax-exempt · ALBANY, NY 12206

Financials

$1.1B$1.1B2023$1.1B$1.2B2024
Revenue Expenses · by fiscal year end
Financials of WORLD FEDERATION OF HEMOPHILIA USA by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990 (amended)$1,095,526,264$1,154,898,723-$59,372,459$377,644,851$345,276$377,299,575
December 31, 2023990$1,131,296,825$1,070,872,912$60,423,913$436,959,567$309,970$436,649,597
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$1,095,452,756
Program service revenue
$0
Investment income
$73,508
Other revenue
$0

Expenses

Grants and similar amounts paid
$1,154,048,112
Compensation of officers, directors and key employees
$0
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Accounting fees
$16,840
Travel
$18,159
Program services (functional)
$1,154,715,802
Management and general (functional)
$122,724
Fundraising (functional)
$60,197

Balance sheet and other

Total assets, start of year
$436,959,567
Total assets, end of year
$377,644,851
Total liabilities, end of year
$345,276
Net assets, end of year
$377,299,575
Publicly traded securities
$1,413,185
Net assets without donor restrictions
$376,152,949
Net assets with donor restrictions
$1,146,626
Gross receipts
$1,095,526,264
Employees
0
Volunteers
13
Year formed
1996
State of legal domicile
NY

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
Len ValentinoPresident
Trustee or director, Officer
1$0
Philip KucabVice-President
Trustee or director, Officer
1$0
Sean SinghTreasurer
Trustee or director, Officer
1$0
Alain BaumannSecretary Exec Director
Trustee or director, Officer, Key employee
4$0
Paula BellBoD member
Trustee or director
1$0
Jeff BlakeBoD member
Trustee or director
1$0
Joanne A DavisBoD member
Trustee or director
1$0
Amy DunnBoD member
Trustee or director
1$0
Rob MaloneyBoD member
Trustee or director
1$0
Glenn PierceBoD member
Trustee or director
1$0
Dawn RotelliniBoD member
Trustee or director
1$0
Frank Schnabel IVBoD member
Trustee or director
1$0
Mark SkinnerBoD member
Trustee or director
1$0
Eric StolteBoD member
Trustee or director
1$0
990 for the year ended December 31, 2023: 11 people
NameTitleHours / weekCompensation
Eric StoltePresident
Trustee or director, Officer
1$0
Len ValentinoVice-President
Trustee or director, Officer
1$0
Sean SinghTreasurer
Trustee or director, Officer
1$0
Alain BaumannSecretary
Trustee or director, Officer, Key employee
4$0
Paula BellDirector
Trustee or director
1$0
Amy DunnDirector
Trustee or director
1$0
Phillip KucabDirector
Trustee or director
1$0
Glenn PierceDirector
Trustee or director
1$0
Mark W SkinnerDirector
Trustee or director
1$0
Frank L Schnabel IVDirector
Trustee or director
1$0
Dawn RotelliniEx-Officio NBDF Liaison
Trustee or director
1$0

Address and contacts

Address (IRS master file)
PMB 142 911 CENTRAL AVE, ALBANY, NY 12206-1350
In care of
% ALAIN BAUMANN
Principal officer (990 for 2024)
Alain Baumann, 1425 Rene Levesque West Suite 1200, MONTREAL, Quebec H3G 1T7, CA
Signed the 990
Alain, Baumann
Phone
(877) 417-7944

Mission

The specific purpose of WFH USA is to advance the global mission of the World Federation of Hemophilia WFH within the United States to improve and sustain care for people with inherited bleeding disorders around the world by developing resources and building awareness within the US for the global vision of Treatment for All.

990 for the year ended December 31, 2024

Program accomplishments

  • The WFH Humanitarian Aid program improves the lack of access to care and treatment by providing support to national member organizations hemophilia treatment centres and healthcare practitioners in emerging countries. This support comes in the form of education training and donated factor and non-factor replacement therapy.The reported $59.37 million deficit is primarily attributable to fluctuations in the value of donated pharmaceutical products which are recorded as in-kind revenue and expense. These are non-cash transactions impacting the total change in net assets without reflecting a change in operating cash flow or program delivery. WFH USA provides tens of thousands of people with hemophilia reliable access to care enabling prophylaxis and elective surgeries in over seventy countries worldwide. Per the Collaboration Agreement with the WFH WFH USA is exclusively responsible for soliciting in-kind contributions of pharmaceutical products and monetary donations for the program. WFH USA periodically grants the received contributions to the WFH as needed to carry out the program.
    Expenses $1,153,880,637 · grants $1,153,186,208 · revenue $1,094,378,239
  • The WFH Training and Education program provides the global bleeding disorders community with the information and tools required to improve access to diagnosis and ensure reliable access to safe treatment and care. Training and education may be delivered through healthcare development programs in-person and virtual workshops and educational events and the development and distribution of educational resources that are available in printed and electronic format. In accordance with the Collaboration agreement between WFH USA and the WFH WFH USA periodically grants contributions received to support the WFH Training and Education programs to the WFH as needed to carry out the WFHs responsibilities with respect to the WFH Training and Education Program.
    Expenses $647,000 · grants $582,300 · revenue $647,000
  • The WFH Research and Data Collection Program includes the Annual Global Survey the World Bleeding Disorder Registry the Gene Therapy Registry and their accompanying education and capacity-building programs. The objective of this program is to provide National Member Organizations NMOs and Hemophilia Treatment Centers HTCs with the tools to increase their capacity the framework to collect data on people with bleeding disorders and the education and training to use that data to conduct research and advocate for better care. In accordance with the Collaboration Agreement between the WFH USA and the WFH WFH USA periodically grants contributions received to support the WFH Research Program to the WFH as needed to carry out the WFHs responsibilities with respect to the WFH Research Program.
    Expenses $155,000 · grants $139,500 · revenue $155,000
  • Other programs include the Awareness Building and Travel Fund. This initiative is dedicated to increasing awareness about bleeding disorders in the United States and worldwide.
    Expenses $33,165

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
16-1513923
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1997
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$377,644,851
Income (IRS master file)
$1,095,526,264

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$1,095,526,264$1,154,898,723$377,644,851XML
990December 2023$1,131,296,825$1,070,872,912$436,959,567XML
990December 2022$684,615,118$684,510,863$1,856,452IRS
990December 2021–––IRS
990December 2020–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 16-1513923).

Questions about WORLD FEDERATION OF HEMOPHILIA USA

What is the EIN of WORLD FEDERATION OF HEMOPHILIA USA?
The employer identification number (EIN) of WORLD FEDERATION OF HEMOPHILIA USA is 16-1513923.
Is WORLD FEDERATION OF HEMOPHILIA USA tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1997.
Are donations to WORLD FEDERATION OF HEMOPHILIA USA tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does WORLD FEDERATION OF HEMOPHILIA USA file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of WORLD FEDERATION OF HEMOPHILIA USA due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did WORLD FEDERATION OF HEMOPHILIA USA last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of WORLD FEDERATION OF HEMOPHILIA USA?
The 990 for the year ended December 31, 2024 names Alain Baumann.
Who are the officers and directors of WORLD FEDERATION OF HEMOPHILIA USA?
The 990 for the year ended December 31, 2024 lists 14 people; 0 received compensation from the organization.
How much revenue does WORLD FEDERATION OF HEMOPHILIA USA have?
On its 990 for the year ended December 31, 2024 it reported revenue of $1,095,526,264, expenses of $1,154,898,723 and total assets of $377,644,851 at year end.

Other nonprofits in ALBANY

All nonprofits in ALBANY · New York · Voluntary health associations and medical disciplines